We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 16 start-ups with an aggregate funding of $634.8m. The average funding per company in this subset is $39.7m.
Last update to the database: Feb 18, 2025. See changelog.
TILT Biotherapeutics is a biotechnology company developing t-cell therapies using onolytic viruses for treating cancer.
2
Funding Rounds
$22.0m
Money raised
Theolytics Ltd is an oncolytic Adenovirus Therapies founded in 2017.
5
Funding Rounds
$65.8m
Money raised
Jivana Biotechnology develops preclinical stage drugs for application in cancer treatment.
1
Funding Rounds
$1.0m
Money raised
Abalos Therapeutics is a viral Immuno-Oncology Treatment founded in 2005.
4
Funding Rounds
$69.0m
Money raised
Turnstone Biologics is an oncolytic viral immunotherapy founded in 2015.
2
Funding Rounds
$121.4m
Money raised
CG Oncology is an Irvine, California-based company.
1
Funding Rounds
$4.7m
Money raised
A biotechnology company that develops virus-driven immunotherapies for cancer
1
Funding Rounds
$885.6k
Money raised
PsiOxus Therapeutics is an oncolytic Vaccines founded in 2010 by Kerry Fisher.
1
Funding Rounds
$22.0m
Money raised
Sagetis Biotech is a company that is committed to developing an innovative polymeric technology
2
Funding Rounds
$2.0m
Money raised
Vyriad is a Rochester, Minnesota-based company founded in 2015.
2
Funding Rounds
$67.3m
Money raised
Oncolytic Immunotherapy
2
Funding Rounds
$75.0m
Money raised
IconOVir Bio is an oncolytic Virus Therapy.
1
Funding Rounds
$77.0m
Money raised
Cold Genesys is a privately-held, immunotherapy based biopharmaceutical company
1
Funding Rounds
$22.0m
Money raised
Immunooncology platform developing tumor antigen-coated oncolytic viruses as therapeutic vaccines.
3
Funding Rounds
$26.7m
Money raised
NousCom is a cancer Immunotherapies founded in 2015.
1
Funding Rounds
$55.0m
Money raised
Cancer Immunotherapy
1
Funding Rounds
$3.0m
Money raised